Correlation Between Sana Biotechnology and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and AN2 Therapeutics, you can compare the effects of market volatilities on Sana Biotechnology and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and AN2 Therapeutics.
Diversification Opportunities for Sana Biotechnology and AN2 Therapeutics
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sana and AN2 is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Sana Biotechnology and AN2 Therapeutics
Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the AN2 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Sana Biotechnology is 1.51 times less risky than AN2 Therapeutics. The stock trades about -0.15 of its potential returns per unit of risk. The AN2 Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 210.00 in AN2 Therapeutics on August 31, 2024 and sell it today you would lose (43.00) from holding AN2 Therapeutics or give up 20.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sana Biotechnology vs. AN2 Therapeutics
Performance |
| Timeline |
| Sana Biotechnology |
| AN2 Therapeutics |
Sana Biotechnology and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sana Biotechnology and AN2 Therapeutics
The main advantage of trading using opposite Sana Biotechnology and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Sana Biotechnology vs. Cue Biopharma | Sana Biotechnology vs. Eliem Therapeutics | Sana Biotechnology vs. Inhibrx | Sana Biotechnology vs. Molecular Partners AG |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |